These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mycophenolate mofetil in pancreas transplantation. Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC. Transplantation; 1998 Aug 15; 66(3):318-23. PubMed ID: 9721799 [Abstract] [Full Text] [Related]
5. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP. Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224 [Abstract] [Full Text] [Related]
6. Reduced dose Thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes. Tan M, Cantarovich M, Mangel R, Paraskevas S, Fortier M, Metrakos P. Clin Transplant; 2002 Dec 27; 16(6):414-8. PubMed ID: 12437620 [Abstract] [Full Text] [Related]
9. Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial. Bösmüller C, Ollinger R, Sieb M, Weissenbacher A, Schneeberger S, Pratschke J, Margreiter R. Ann Transplant; 2012 Dec 31; 17(4):45-51. PubMed ID: 23274323 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I. Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404 [Abstract] [Full Text] [Related]